FDA Analysis Chills the Rush to Approve Boosters FDA Analysis Chills the Rush to Approve Boosters

An FDA report released this week has added doubt to the outcome of an advisory committee meeting on Friday to consider a third booster dose for the Pfizer COVID vaccines.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news